Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma

Kevin C. Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L. Wellinghoff, Natalie A. LaFranzo, Zachary S. Bradley, Joey Babbitt, William H. Westra, Raymond Hsu, Lincoln Nadauld, Howard Mcleod, Sean D. Firth, Brittany Sharp, Josh Fuller, Vera Vavinskaya, Leisa Sutton, Ida Deichaite, Samuel D. Bailey, Vlad C. Sandulache, Matthew J. Rendo, Orlan K. Macdonald, Karim Welaya, James L. Wade, Andrew W. Pippas, Jennifer Slim, Bruce Bank, Steven J. Saccaro, Xingwei Sui, Adil Akhtar, Savitha Balaraman, Steven E. Kossman, Scott A. Sonnier, Todd D. Shenkenberg, Warren L. Alexander, Katherine A. Price, Charles L. Bane, Jessica Ley, David N. Messina, Jarret I. Glasscock, Ezra E. W. Cohen, Douglas R. Adkins, Eric J. Duncavage

Open source

DOI: 10.1007/s00432-023-05205-z
Published: 2023-08-08
Container: Journal of Cancer Research and Clinical Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00432-023-05205-z,
  title = {Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma},
  author = {Kevin C. Flanagan and Jon Earls and Ian Schillebeeckx and Jeffrey Hiken and Rachel L. Wellinghoff and Natalie A. LaFranzo and Zachary S. Bradley and Joey Babbitt and William H. Westra and Raymond Hsu and Lincoln Nadauld and Howard Mcleod and Sean D. Firth and Brittany Sharp and Josh Fuller and Vera Vavinskaya and Leisa Sutton and Ida Deichaite and Samuel D. Bailey and Vlad C. Sandulache and Matthew J. Rendo and Orlan K. Macdonald and Karim Welaya and James L. Wade and Andrew W. Pippas and Jennifer Slim and Bruce Bank and Steven J. Saccaro and Xingwei Sui and Adil Akhtar and Savitha Balaraman and Steven E. Kossman and Scott A. Sonnier and Todd D. Shenkenberg and Warren L. Alexander and Katherine A. Price and Charles L. Bane and Jessica Ley and David N. Messina and Jarret I. Glasscock and Ezra E. W. Cohen and Douglas R. Adkins and Eric J. Duncavage},
  year = {2023},
  journal = {Journal of Cancer Research and Clinical Oncology},
  doi = {10.1007/s00432-023-05205-z},
  url = {https://doi.org/10.1007/s00432-023-05205-z}
}

RIS

TY  - JOUR
TI  - Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
AU  - Kevin C. Flanagan
AU  - Jon Earls
AU  - Ian Schillebeeckx
AU  - Jeffrey Hiken
AU  - Rachel L. Wellinghoff
AU  - Natalie A. LaFranzo
AU  - Zachary S. Bradley
AU  - Joey Babbitt
AU  - William H. Westra
AU  - Raymond Hsu
AU  - Lincoln Nadauld
AU  - Howard Mcleod
AU  - Sean D. Firth
AU  - Brittany Sharp
AU  - Josh Fuller
AU  - Vera Vavinskaya
AU  - Leisa Sutton
AU  - Ida Deichaite
AU  - Samuel D. Bailey
AU  - Vlad C. Sandulache
AU  - Matthew J. Rendo
AU  - Orlan K. Macdonald
AU  - Karim Welaya
AU  - James L. Wade
AU  - Andrew W. Pippas
AU  - Jennifer Slim
AU  - Bruce Bank
AU  - Steven J. Saccaro
AU  - Xingwei Sui
AU  - Adil Akhtar
AU  - Savitha Balaraman
AU  - Steven E. Kossman
AU  - Scott A. Sonnier
AU  - Todd D. Shenkenberg
AU  - Warren L. Alexander
AU  - Katherine A. Price
AU  - Charles L. Bane
AU  - Jessica Ley
AU  - David N. Messina
AU  - Jarret I. Glasscock
AU  - Ezra E. W. Cohen
AU  - Douglas R. Adkins
AU  - Eric J. Duncavage
PY  - 2023
JO  - Journal of Cancer Research and Clinical Oncology
DO  - 10.1007/s00432-023-05205-z
UR  - https://doi.org/10.1007/s00432-023-05205-z
ER  -

APA

Flanagan, K. C., Earls, J., Schillebeeckx, I., Hiken, J., Wellinghoff, R. L., LaFranzo, N. A., Bradley, Z. S., Babbitt, J., Westra, W. H., Hsu, R., Nadauld, L., Mcleod, H., Firth, S. D., Sharp, B., Fuller, J., Vavinskaya, V., Sutton, L., Deichaite, I., Bailey, S. D., Sandulache, V. C., Rendo, M. J., Macdonald, O. K., Welaya, K., Wade, J. L., Pippas, A. W., Slim, J., Bank, B., Saccaro, S. J., Sui, X., Akhtar, A., Balaraman, S., Kossman, S. E., Sonnier, S. A., Shenkenberg, T. D., Alexander, W. L., Price, K. A., Bane, C. L., Ley, J., Messina, D. N., Glasscock, J. I., Cohen, E. E. W., Adkins, D. R., & Duncavage, E. J. (2023). Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-05205-z

Source records

crossref · retrieved 2026-09-26T03:05:15.434Z